UK markets closed

International Stem Cell Corporation (ISCO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0970-0.0120 (-11.01%)
At close: 10:10AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
7,593
7,789
8,180
7,176
7,128
Cost of revenue
2,868
3,181
3,269
2,935
2,781
Gross profit
4,725
4,608
4,911
4,241
4,347
Operating expenses
Research development
570
511
492
695
988
Selling general and administrative
4,722
4,760
4,602
5,467
6,177
Total operating expenses
5,292
5,271
5,094
6,162
7,165
Operating income or loss
-567
-663
-183
-1,921
-2,818
Interest expense
133
139
135
128
113
Total other income/expenses net
-5
671
-13
1,150
207
Income before tax
-705
-131
-331
-899
-2,724
Income from continuing operations
-705
-131
-331
-899
-2,724
Net income
-705
-131
-331
-899
-2,724
Net income available to common shareholders
-705
-131
-331
-899
-2,724
Basic EPS
0.02
-
-0.04
-0.11
-0.36
Diluted EPS
0.02
-
-0.04
-0.11
-0.36
Basic average shares
8,004
-
8,004
7,833
7,539
Diluted average shares
8,004
-
8,004
7,833
7,539